| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |